These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 6105342)

  • 1. Propranolol--a medical treatment for portal hypertension?
    Lebrec D; Nouel O; Corbic M; Benhamou JP
    Lancet; 1980 Jul; 2(8187):180-2. PubMed ID: 6105342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.
    Lebrec D; Hillon P; Muńoz C; Goldfarb G; Nouel O; Benhamou JP
    Hepatology; 1982; 2(5):523-7. PubMed ID: 6981575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol and haemorrhage due to rupture of oesophageal varices.
    Dobrilla G; de Pretis G
    Hepatogastroenterology; 1984 Dec; 31(6):245-7. PubMed ID: 6394464
    [No Abstract]   [Full Text] [Related]  

  • 4. [Propranolol in the prevention of digestive bleeding in cirrhotic patients].
    Sotto A; Castro R; Glez Cansino J
    Acta Gastroenterol Latinoam; 1989; 19(1):15-20. PubMed ID: 2690549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trial of propranolol to prevent recurrent variceal bleeding in patients with non-cirrhotic portal fibrosis.
    Kiire CF
    BMJ; 1989 May; 298(6684):1363-5. PubMed ID: 2502256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study.
    Lebrec D; Poynard T; Hillon P; Benhamou JP
    N Engl J Med; 1981 Dec; 305(23):1371-4. PubMed ID: 7029276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug therapy for portal hypertension.
    Rector WG
    Ann Intern Med; 1986 Jul; 105(1):96-107. PubMed ID: 2872847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis.
    Kong CW; Lay CS; Tsai YT; Lee SD; Lai KH; Lo KJ; Chiang BN
    Dig Dis Sci; 1986 Dec; 31(12):1303-6. PubMed ID: 3803132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term effects of propranolol on portal pressure in cirrhotic patients.
    Orban-Schiopu AM; Popescu CR
    Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy of portal hypertension and oesophageal varices.
    Hayes P; Bouchier IA
    Br J Hosp Med; 1984 Jul; 32(1):39-42. PubMed ID: 6146364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol reduces variceal pressure and wall tension in schistosomiasis presinusoidal portal hypertension.
    Farias AQ; Kassab F; da Rocha EC; Dos Santos Bomfim V; Vezozzo DC; Bittencourt PL; Carrilho FJ
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1852-6. PubMed ID: 19686417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group.
    Conn HO; Grace ND; Bosch J; Groszmann RJ; Rodés J; Wright SC; Matloff DS; Garcia-Tsao G; Fisher RL; Navasa M
    Hepatology; 1991 May; 13(5):902-12. PubMed ID: 2029994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of recurrent hemorrhage due to portal hypertension].
    Lebrec D
    Schweiz Med Wochenschr; 1986 Apr; 116(17):552-4. PubMed ID: 3487112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The medical prevention of variceal bleeding.
    Lebrec D
    Intensive Care Med; 1988; 14(2):97-9. PubMed ID: 3283193
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis.
    Hillon P; Lebrec D; Muńoz C; Jungers M; Goldfarb G; Benhamou JP
    Hepatology; 1982; 2(5):528-31. PubMed ID: 7118065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage.
    Groszmann RJ; Bosch J; Grace ND; Conn HO; Garcia-Tsao G; Navasa M; Alberts J; Rodes J; Fischer R; Bermann M
    Gastroenterology; 1990 Nov; 99(5):1401-7. PubMed ID: 2210246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of hemorrhage from esophageal varices in patients with liver cirrhosis by administration of propranolol].
    López Fuerte F; Cárdenas Rojas JA; Esquivel López A; Perches Vega A
    Rev Gastroenterol Mex; 1986; 51(4):187-90. PubMed ID: 3502507
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension.
    Gatta A; Sacerdoti D; Merkel C; Milani L; Battaglia G; Zuin R
    Am Heart J; 1984 Oct; 108(4 Pt 2):1167-72. PubMed ID: 6148880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
    García-Pagán JC; Feu F; Bosch J; Rodés J
    Ann Intern Med; 1991 May; 114(10):869-73. PubMed ID: 2014947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of propranolol on hepatic blood flow in normal and portal hypertensive rats.
    Hillon P; Blanchet L; Lebrec D
    Clin Sci (Lond); 1982 Jul; 63(1):29-32. PubMed ID: 7083761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.